Ernexa Therapeutics Selected for Emerging Track at 2026 Cell & Gene Meeting on the Mesa, Highlighting ERNA-101 and Focused Oncology Strategy

Barchart · 1d ago

Ernexa selected for the Emerging Track, recognizing the Company among emerging
innovators in the cell and gene therapy sector

President & CEO Sanjeev Luther to deliver an Innovation Spotlight presentation on
October 6, 2026, at 1:30 PM

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.